Community/Retail

Urges continued distinction between prescription compounding and manufacturing

The proposed Medicare Prescription Drug Program Integrity and Transparency Act would reform Medicare Part D pharmacy audits and increase transparency in maximum allowable cost lists.

A diabetes care team that included a clinical pharmacist led to major improvements in glycemic control, LDL cholesterol levels, blood pressure, and long-term cardiovascular risk.

A spirit of inquisitiveness and lifelong learning is essential to meeting the needs of pharmacy in the 21st century.

Over the past year, promising studies have been published dealing with autism and early intervention, pharmacologic treatment, early diagnosis, and delayed speaking abilities.

An emergency fund can provide invaluable peace of mind if you find yourself facing unexpected expenses.

Many glaucoma patients take vitamin supplements as part of their therapy, but a new study finds little evidence that they help prevent the condition from developing.

A survey of US neurologists found that a significant minority is unaware of FDA drug safety updates and many who are aware of the updates fail to act on them.

The FDA approved the emergency contraceptive to be sold OTC to girls aged 15 and older, and the Justice Department appealed a judge's order that it be made available OTC to girls of all ages.

The finding that cholesterol can cause chromosomal aberrations common to Alzheimer's disease and Down syndrome may help lead to new therapies.

A study of patients hospitalized with acute coronary syndrome found that delays between symptom onset and arrival at the emergency department were largely due to patient hesitancy to seek treatment.

A study including more than half a million Danish children finds that children born to mothers who took the antiepileptic drug valproate during pregnancy were much more likely to develop autism.

New guidelines from the American Association of Clinical Endocrinologists cover therapy with all approved classes of diabetes drugs as well as obesity, prediabetes, and cardiovascular risk factor management.

The FDA's restricted distribution programs, intended for medications with toxicity risks or other potential dangers, may also be used to impede biosimilar competition, according to a Federal Trade Commission amicus brief filed in the US District Court for the District of New Jersey.

Survey Finds Shortages Leading to Treatment Delays, Missed Doses

Among patients admitted to the hospital with acute coronary syndrome, women and black patients expressed increased concerns about aspirin therapy, which was correlated with lower adherence.